HomeAUPH • NASDAQ
add
Aurinia Pharmaceuticals Inc
Nakaraang pagsara
$14.27
Sakop ng araw
$13.33 - $14.44
Sakop ng taon
$6.56 - $16.20
Market cap
1.89B USD
Average na Volume
1.72M
P/E ratio
25.60
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 70.01M | 22.41% |
Gastos sa pagpapatakbo | 35.26M | -21.01% |
Net na kita | 21.51M | 2,879.64% |
Net profit margin | 30.73 | 2,338.89% |
Kita sa bawat share | 0.16 | 1,500.00% |
EBITDA | 25.06M | 469.31% |
Aktuwal na % ng binabayarang buwis | 2.90% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 315.04M | -4.63% |
Kabuuang asset | 502.56M | -4.00% |
Kabuuang sagutin | 167.26M | 5.25% |
Kabuuang equity | 335.30M | — |
Natitirang share | 131.63M | — |
Presyo para makapag-book | 5.64 | — |
Return on assets | 10.02% | — |
Return on capital | 11.95% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 21.51M | 2,879.64% |
Cash mula sa mga operasyon | 44.24M | 179.25% |
Cash mula sa pag-invest | -13.27M | 65.63% |
Cash mula sa financing | -44.39M | -436.61% |
Net change in cash | -13.43M | 56.76% |
Malayang cash flow | 29.57M | 69.37% |
Tungkol
Itinatag
2012
Headquarters
Website
Mga Empleyado
130
